Functional, Structural, and Disease Applications
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 13 - 38
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 39 - 72
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 138 - 66
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 139 - 153
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 155 - 170
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 171 - 191
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 193 - 222
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 223 - 239
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 241 - 254
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 255 - 272
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 273 - 283
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 285 - 300
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 301 - 322
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 323 - 333
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 335 - 357
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 359 - 374
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 375 - 397
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 399 - 413
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 415 - 437
Wiley Series in Drug Discovery and Development > Drug Design of Zinc‐Enzyme Inhibitors > Drug Design of Carbonic Anhydrase Inhibitors and Activators > 439 - 472